Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and Aims : The natural immunomodulator, lactoferrin, is widespread among various biological fluids and is known to exert an anti‐inflammatory effect. However, there has been only one study that examined the mode of action of lactoferrin in reducing intestinal damage. We investigated the therapeutic role of lactoferrin and its effect on the levels of pro‐inflammatory and anti‐inflammatory cytokines, by using a rat model of dextran sulfate sodium (DSS) induced‐colitis. Methods: Male Sprague–Dawley rats were given distilled drinking water containing 2.5% (wt/vol) synthetic DSS ad libitum. Bovine lactoferrin was given once daily through gavage, starting 3 days before beginning the DSS administration, until death. The whole colon was removed to be examined macroscopically and histologically. Myeloperoxidase activity, and pro‐inflammatory and anti‐inflammatory cytokines in the colonic tissue were also measured. Results: Dextran sulfate sodium‐induced colitis was attenuated by oral administration of lactoferrin in a dose‐dependent manner, as reflected by improvement in clinical disease activity index, white blood cell count and hemoglobin concentration, macroscopic and histological scores, and myeloperoxidase activity. Reduced inflammation in response to lactoferrin was correlated with the significant induction of the anti‐inflammatory cytokines, interleukin‐4 and interleukin‐10, and with significant reductions in the pro‐inflammatory cytokines, tumor necrosis factor α, interleukin‐1β, and interleukin‐6. Conclusions: We concluded that oral administration of lactoferrin exerts a protective effect against the development of colitis in rats via modulation of the immune system and correction of cytokine imbalance. Lactoferrin has potential as a new therapeutic agent for inflammatory bowel disease. © 2002 Blackwell Publishing Asia Pty Ltd
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lactoferrin: molecular structure and biological function
Lönnerdal, B., & Iyer, S. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.000521 · Cited by 781
Regulation of cytokine release from mononuclear cells by the iron- binding protein lactoferrin
Crouch, S., Slater, K., & Fletcher, J. (1992) · Blood · doi:10.1182/blood.v80.1.235.235 · Cited by 294
Cited by
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
Legrand, D., Elass, E., Carpentier, M., & Mazurier, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5370-2 · Cited by 420
Lactoferrin research, technology and applications
Wakabayashi, H., Yamauchi, K., & Takase, M. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.013 · Cited by 354
Lactoferrin in a Context of Inflammation-Induced Pathology
Kruzel, M. L., Zimecki, M., & Actor, J. K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01438 · Cited by 305
Legrand, D. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-056 · Cited by 193
Metadata
- Authors
- TOGAWA, J., NAGASE, H., TANAKA, K., INAMORI, M., NAKAJIMA, A., UENO, N., SAITO, T., & SEKIHARA, H.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2002-11-07
- Volume
- 17
- Issue
- 12
- Pages
- 1291-1298
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2071649876
- Cited by
- 133
- References
- 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. https://app.cochat.ai/papers/10.1046/j.1440-1746.2002.02868.x
- The paper
- TOGAWA, J., NAGASE, H., TANAKA, K., INAMORI, M., NAKAJIMA, A., UENO, N., SAITO, T., & SEKIHARA, H. (2002). Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Journal of Gastroenterology and Hepatology. https://doi.org/10.1046/j.1440-1746.2002.02868.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.